Shoppers can’t stop praising Neutrogena’s Triple Age Repair Anti-Aging Night Cream, which is currently on sale for $18 on Amazon ... Night Cream is packed with vitamin C and glycerin to ...

Secure allocated parking, low service charge and walking distance to the immediate City. This property is for sale by Modern Method of Auction allowing the buyer and seller to complete within a 56 Day ...

An ultra-high dose of mecobalamin, a naturally occurring form of vitamin B12, has been approved in Japan under the brand name Rozebalamin ... Mecobalamin is highly sensitive to light, which can cause ...

One important detail: this is an Amazon Lightning Deal, so the sale price is time — and supply — limited. To shop the Lightning Deal, scroll below. Save 10 per cent on this vitamin C serum ...

The analysis revealed that higher serum vitamin B12 levels were strongly associated with a reduced risk of developing different types of pancreatitis. Next, the team determined whether vitamin B12 ...

It has largely remained a mystery as to what the bottles of product were used for, but a recent legal filing may have just revealed the truth. Developments came on Monday after an alleged victim ...

Police in Italy searched 14 properties and seized large amounts of wine, wine bottles, counterfeit stickers ... to an Italian airport and exported for sale at market value all over the world ...

NEW YORK – BioMérieux announced on Tuesday that it has obtained the CE mark for an assay to detect vitamin B12. The automated, quantitative test runs on the firm's Vidas immunoanalyzers. Vitamin B12 ...

A new study suggests that Medicare could save up to $366 million annually by introducing a new vial size for Alzheimer's drug lecanemab, which is currently only available in single-use ...

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. About 6% of Leqembi ...

In addition, replacing the 500 mg vial with a 250 mg presentation could lower the overall drug waste from 5.8% to 3.2%, creating up to $155 million in annul savings, the team found.

Assuming conservative lecanemab uptake rates of 1.1–2.9% for an estimated 82,000 to 208,000 of eligible people, current vial sizes would lead to an estimated $133 million to $336 million worth ...